MLH1 and cancer: In LS, one allele of MLH1, MSH2, MSH6, or PMS2 is mutant in every cell and causes cancer predisposition, but tumors usually do not develop until a “second hit” inactivates the remaining wild‐type allele in a cancer‐prone target tissue, such as colonic mucosa or uterine endometrium.